期刊文献+

Ⅰ型和Ⅱ型子宫内膜癌临床病理特点对比分析 被引量:3

Comparative analyses of clinical and pathological characteristics between types 1 and 2 endometrial uterine cancers
原文传递
导出
摘要 目的 探讨Ⅰ型和Ⅱ型子宫内膜癌的临床病理特点.方法 回顾性分析2000年1月至2010年12月广东省子宫内膜癌防治项目协作医院子宫内膜癌的临床资料,并依据组织学类型分成Ⅰ型子宫内膜癌(9 138例)和Ⅱ型子宫内膜癌(299例)两组,进行对比分析.结果 Ⅰ型子宫内膜癌患者发病年龄低于Ⅱ型(P<0.05),年轻患者比例高于Ⅱ型(P<0.05).Ⅱ型子宫内膜癌患者绝经年龄高于Ⅰ型(P<0.05).Ⅰ型和Ⅱ型子宫内膜癌在初潮年龄以及合并肥胖、糖尿病、高血压、不孕、未产方面比较差异均无统计学意义(P>0.05).Ⅱ型子宫内膜癌的晚期(Ⅲ期和Ⅳ期)、深肌层浸润、雌激素受体(ER)阴性、孕激素受体(PR)阴性、P53阳性、淋巴脉管间隙受累、宫颈间质浸润、腹水细胞学阳性、附件转移、淋巴结转移的发生率高于Ⅰ型(P<0.05).结论 Ⅱ型子宫内膜癌患者年龄较大,病理危险因素多,生物学恶性程度高. Objective To investigate the clinical and pathological characteristics between types 1 and 2 endometrial uterine cancers.Methods The clinical materials of 9 437 patients with uterine cancer were collected with retrospective analysis from 62 hospitals during 2000 to 2010.Results The mean age of type 1 endometrial cancers was less than type 2.There were more young patients in type 1 endometrial cancers.The mean menopause age of type 2 endometrial cancers was greater than type 1.The mean age of menarche,obesity,diabetes,hypertension,infertility,and nulliparous were not significant differences between types 1 and 2 endometrial cancers.There were more patients with advanced tumor,deep myometrium invasion,estrogen receptor (ERs) negative,progesterone receptor (PR) negative,P53 positive,lymph vascular space involvement,cervical stromal invasion,adnexal metastasis,and lymph node metastasis in type 2 endometrial cancers.Conclusions Type 2 endometrial uterine cancers occurred in elder people with more pathological risk factors and more malignant biological activities.
出处 《中国医师杂志》 CAS 2015年第8期1124-1126,共3页 Journal of Chinese Physician
基金 国家自然科学基金资助项目(30772332) 广东省自然科学基金资助项目(S2012010008640) 广东省妇幼安康工程-子宫内膜癌防治项目
关键词 子宫内膜肿瘤 病理学 Endometrial neoplasms/PA
  • 相关文献

参考文献7

  • 1Bokhman JV. Two pathogenetic types of endometrial carcinoma[J]. Gynecol Oncol, 1983,15(1):10-17.
  • 2Ulrich LS. Endometrial cancer, types, prognosis, female hor-mones and antihorraones [ J ]. Climacteric,2011,14 (4) : 418-425.
  • 3Duong LM, Wilson RJ, Ajani UA, et al. Trends in,endometrial> cancer incidence rates in the United States, 1999-2006 [ J ]. JWomens Health (Larchmt),2011,20(8) :1157-1163.
  • 4李小毛,叶辉霞.非子宫内膜样腺癌组织学类型及临床特点[J].广东医学,2010,31(22):2997-3000. 被引量:8
  • 5Bassarak N, Blankenstein T, Bruning A, et al. Is lymphadenecto-my a prognostic marker in endometrioid adenocarcinoma of the hu-man endometrium. [J]. BMC Cancer,2010,10:224.
  • 6Mendivil A, Schuler KM, Gehrig PA. Non-endometrioid adeno-carcinoma of the uterine corpus : a review of selected histologicalsubtypes[ J]. Cancer Control,2009,16( 1) :46-52.
  • 7李小毛,郑泽纯,叶辉霞,马利国,刘继红,林仲秋.子宫浆液性癌101例临床分析[J].中国妇产科临床杂志,2015,16(1):26-29. 被引量:11

二级参考文献35

  • 1廖晓耘,王恩杰,吕晓红,李荣,沈丹华.子宫浆液性癌及内膜上皮内癌临床病理分析[J].临床与实验病理学杂志,2006,22(1):36-41. 被引量:4
  • 2BOKHMAN J V.Two pathogenetic types of endometrial carcinoma[J].Gynecol Oncol,1983,15(1):10-17.
  • 3HENDRICKSON M,ROSS J,EIFEL P,et al.Uterine papillary serous carcinoma:a highly malignant form of endometrial adenocarcinoma[J].Am J Surg Pathol,1982,6(2):93-110.
  • 4MENDIVIL A,SCHULER K M,GEHRIG P A.Non-endometrioid adenocarcinoma of the uterine Corpus:a review of selected histological subtypes[J].Cancer Control,2009,16(1):46-52.
  • 5HOLCOMB K,DELATORRE R,PEDEMONTE B,et al.E-cadherin expression in endometrioid,papillary serous,and clear cell carcinoma of the endometrium[J].Obstet Gynecol,2002,100(6):1290-1295.
  • 6AL HUSSAINI M,STOCKMAN A,FOSTER H,et al.WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma[J].Histopathology,2004,44(2):109-115.
  • 7BROWN L.Pathology of uterine malignancies[J].Clin Oncol (R Coll Radiol),2008,20(6):433-447.
  • 8ACHARYA S,HENSLEY M L,MONTAG A C,et al.Rare uterine cancers[J].Lancet Oncol,2005,6(12):961-971.
  • 9SLOMOVITZ B M,BURKE T W,EIFEL P J,et al.Uterine papillary serous carcinoma (UPSC):a single institution review of 129 cases[J].Gynecol Oncol,2003,91(3):463-469.
  • 10TROP(E) C,KRISTENSEN G B,ABELER V M.Clear-cell and papillary serous cancer:treatment options[J].Best Pract Res Clin Obstet Gynaecol,2001,15(3):433-446.

共引文献15

同被引文献42

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部